首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1358093

勃起功能障碍药物市场：按药物、给药途径、配销通路和地区

Erectile Dysfunction Treatment Market, By Drugs (Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil, Others), By Route of Administration, By Distribution Channel, By Geography

出版日期: 2023年09月05日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2023 年全球勃起功能障碍药物市场价值 45.4 亿美元，预计在预测期内（2023-2030 年）年复合成长率为 7.6%。

报告范围		报告详情
基准年	2022年	2023年市场规模	45.4亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	7.60%	2030年市场规模预测	75.7亿美元

勃起功能障碍药物的全球市场占有率（%），按产品类型，2023年

勃起功能障碍 (ED)，通常也称为阳痿，是一种以持续或反覆无法实现和维持足以进行令人满意的性活动的勃起为特征的疾病。犀利士（威而钢）、他达拉非（犀利士）、伐地那非（艾力达、Staxyn）、阿伐那非（Stendra）、乌地那非（Zydena）和其他药物透过放鬆阴茎肌肉、增加血流量和促进勃起发挥作用。增加一氧化氮（体内的天然化学物质）的作用。

市场动态

市场上的主要企业正在专注于无机成长策略，例如勃起功能障碍（ED）的收购和交易，预计将在预测期内推动全球勃起功能障碍药物市场的成长。例如，2022年5月，私人专业製药公司Aspargo Laboratories, Inc.宣布从总公司西班牙巴塞隆纳的专业製药公司Laboratorios Rubio SA手中收购了处方药品牌BANDOL（西地那非口服混悬液）。它已经收购。 BANDOL 是一种治疗勃起功能障碍（ED）的药物。此外，2023年3月，迪科特开始研发促效剂，目标是成为治疗勃起功能障碍的第一线药物，我们已与迪科特博士签订了顾问合约。 Padma-Nathan 博士参与了目前在新兴市场销售的勃起功能障碍药物的开发，包括在威而钢和犀利士的开发过程中担任首席研究员。他关于威而钢的文章发表在《新英格兰医学杂誌》上，是泌尿系统领域被引用次数最多的文章。

本研究的主要特点

该报告对全球勃起功能障碍治疗药物市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和復合年度（年复合成长率）。它还阐明了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数对全球勃起功能障碍治疗药物市场的主要企业进行了分析。
本研究涵盖的主要企业包括 Mangoceuticals, Inc、Futura Medical、CURE Pharmaceutical Holding Corp、Glenmark Pharmaceuticals Ltd、Mylan Pharmaceuticals Inc、Boston Scientific、Cipla Ltd、Pfizer Inc、Coloplast CORP、Eli Lily &Co、Gust Inc、Altera、Promedon、 Dr. Reddys Laboratories Ltd、Bayer Pharma AG 和Reflexonic LLC。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
全球勃起功能障碍治疗药物市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球勃起功能障碍治疗药物市场的各种策略矩阵来促进他们的决策。

公司简介
- Mangoceuticals, Inc.
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc
- Boston Scientific
- Cipla Ltd
- Pfizer Inc
- Coloplast CORP
- Eli Lily &Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC

第10章章

参考
调查方法

简介目录

Product Code: CMI200

The global erectile dysfunction treatment market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.54 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.60%	2030 Value Projection:	US$ 7.57 Bn

Global Erectile Dysfunction Treatment Market Share (%), By Product Type, 2023

Erectile Dysfunction Treatment Market - IMG1

Erectile Dysfunction (ED), also commonly referred to as impotence, is a medical condition characterized by the consistent or recurrent inability to achieve and maintain an erection sufficient for satisfactory sexual activity. Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra, Staxyn), Avanafil (Stendra), Udenafil (Zydena), and other medications work by enhancing the effects of nitric oxide, a natural chemical in the body that relaxes the muscles in the penis, allowing for increased blood flow and thus facilitating an erection.

Market Dynamics

The key players in operating in the market are focusing on inorganic growth strategies such as acquisitions and agreements for Erectile Dysfunction (ED), which is expected to propel the global erectile dysfunction treatment market growth over the forecast period. For instance, in May 2022, Aspargo Laboratories, Inc., a privately-held specialty pharmaceutical company, announced the acquisition of the prescription brand, BANDOL (sildenafil oral suspension) from Laboratorios Rubio S.A., a specialty pharmaceutical company headquartered in Barcelona, Spain. BANDOL is indicated for the treatment of Erectile Dysfunction (ED). Moreover, in March 2023, Dicot is a pharmaceutical company started developing a novel potency drug aimed to become the first choice for treatment of erectile dysfunction, and entered into a consultancy agreement with Dr.Harin Padma-Nathan, a world leading medical expert in male sexual dysfunctions. Dr. Padma-Nathan was involved in the development of the drugs for erectile dysfunction currently on the market, e.g., as Lead Principal Investigator during the development of Viagra and Cialis. His Viagra paper in The New England Journal of Medicine is the most cited paper in the field of urology.

Key features of the study:

This report provides an in-depth analysis of the global erectile dysfunction treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global erectile dysfunction treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Mangoceuticals, Inc, Futura Medical, CURE Pharmaceutical Holding Corp, Glenmark Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc., Boston Scientific, Cipla Ltd , Pfizer Inc., Coloplast CORP, Eli Lily & Co, Gust Inc, Altera, Promedon, Dr. Reddys Laboratories Ltd, Bayer Pharma AG, and Reflexonic LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global erectile dysfunction treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global erectile dysfunction treatment market

Erectile Dysfunction Treatment Market Detailed Segmentation:

By Drugs:
- Sildenafil (Viagra)
- Vardenafil (Levitra Staxyn)
- Tadalafil (Cialis)
- Avanafil (Stendra)
- Udenafil (Zydena)
- Others
By Route of Administration:
- Oral drugs
- Injections
- Topical application
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Mangoceuticals, Inc.
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc.,
- Boston Scientific
- Cipla Ltd
- Pfizer Inc.,
- Coloplast CORP
- Eli Lily & Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Erectile Dysfunction Treatment Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Erectile Dysfunction Treatment Market, By Drugs, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Sildenafil (Viagra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Vardenafil (Levitra Staxyn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Tadalafil (Cialis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Avanafil (Stendra)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Udenafil (Zydena)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Erectile Dysfunction Treatment Market, By Route of Administration, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Oral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Topical Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Erectile Dysfunction Treatment Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Erectile Dysfunction Treatment Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drugs, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Mangoceuticals, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Futura Medical
- CURE Pharmaceutical Holding Corp
- Glenmark Pharmaceuticals Ltd
- Mylan Pharmaceuticals Inc
- Boston Scientific
- Cipla Ltd
- Pfizer Inc
- Coloplast CORP
- Eli Lily & Co
- Gust Inc
- Altera
- Promedon
- Dr. Reddys Laboratories Ltd
- Bayer Pharma AG
- Reflexonic LLC